HIVe Home
Posted: 26 Oct 2011
Postdoctoral Positions at NCI (NIH)
Type of Position: Full-time   
Apply Here
Deadline: 1 Jan 2038
National Cancer Institute (NIH)
The National Cancer Institute (NCI) is part of the National Institutes of Health (NIH), which is one of 11 agencies that compose the Department of Health and Human Services (HHS). The NCI, established under the National Cancer Institute Act of 1937, is the Federal Government's principal agency for cancer research and training. The National Cancer Act of 1971 broadened the scope and responsibilities of the NCI and created the National Cancer Program. Over the years, legislative amendments have maintained the NCI authorities and responsibilities and added new information dissemination mandates as well as a requirement to assess the incorporation of state-of-the-art cancer treatments into clinical practice. The National Cancer Institute coordinates the National Cancer Program, which conducts and supports research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients.
Visit web site

Postdoctoral positions are available in the Retrovirus Assembly Section of the HIV Drug Resistance Program, National Cancer Institute, to perform basic research on mechanisms of virus assembly and RNA recognition during retroviral replication. These studies involve detailed characterization of recombinant viral proteins in solution and in virus-like particles assembled in defined in vitro  systems. Of particular interest are the interactions of retroviral Gag proteins with each other and with nucleic acids, both in vitro  and in mammalian cells in culture. The laboratory also studies interactions between retroviruses and antiviral factors present in mammalian cells. Further details can be found at


Interested candidates must possess a Ph.D. and/or an M.D. To apply, send a cover letter, CV including bibliography, and contact information for three references to the address listed under "Contact Information."


Dr. Alan Rein

Retrovirus Assembly Section

HIV Drug Resistance Program, National Cancer Institute

NCI-Frederick, P.O. Box B

Building 535, Room 211

Frederick, MD 21702-1201

E-mail: reina@mail.nih.go